Literature DB >> 9932481

Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs).

D M Juilfs1, S Soderling, F Burns, J A Beavo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9932481     DOI： 10.1007/bfb0033670

Source DB:  PubMed          Journal:  Rev Physiol Biochem Pharmacol        ISSN： 0303-4240            Impact factor:   5.545


× No keyword cloud information.
  34 in total

Review 1.  The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.

Authors:  Tomas C Bellamy; John Garthwaite
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

2.  KMUP-1 relaxes rabbit corpus cavernosum smooth muscle in vitro and in vivo: involvement of cyclic GMP and K(+) channels.

Authors:  Rong-Jyh Lin; Bin-Nan Wu; Yi-Ching Lo; Kuo-Pyng Shen; Young-Tso Lin; Chun-Hsiung Huang; Ing-Jun Chen
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

3.  Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.

Authors:  K S Murthy
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

4.  In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylation.

Authors:  Florian Mullershausen; Michael Russwurm; Doris Koesling; Andreas Friebe
Journal:  Mol Biol Cell       Date:  2004-07-07       Impact factor: 4.138

5.  PDE1B2 regulates cGMP and a subset of the phenotypic characteristics acquired upon macrophage differentiation from a monocyte.

Authors:  Andrew T Bender; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

6.  Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.

Authors:  M S H El-Awady; S V Smirnov; M L Watson
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

7.  A phosphodiesterase 2A isoform localized to mitochondria regulates respiration.

Authors:  Rebeca Acin-Perez; Michael Russwurm; Kathrin Günnewig; Melanie Gertz; Georg Zoidl; Lavoisier Ramos; Jochen Buck; Lonny R Levin; Joachim Rassow; Giovanni Manfredi; Clemens Steegborn
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

Review 8.  The role of phosphodiesterases in schizophrenia : therapeutic implications.

Authors:  Judith A Siuciak
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.

Authors:  Haroldo A Toque; Fernanda B M Priviero; Saiprasad M Zemse; Edson Antunes; Cleber E Teixeira; R Clinton Webb
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-10-15       Impact factor: 2.557

10.  Phosphodiesterase type 5 inhibitors increase Herceptin transport and treatment efficacy in mouse metastatic brain tumor models.

Authors:  Jinwei Hu; Julia Y Ljubimova; Satoshi Inoue; Bindu Konda; Rameshwar Patil; Hui Ding; Andres Espinoza; Kolja A Wawrowsky; Chirag Patil; Alexander V Ljubimov; Keith L Black
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.